Electronic Informed Consent in Clinical Research

Medidata is conducting a research to have an understanding of the regulatory positions, adoption and the variability regarding electronic educated consent (eConsent) all-around the planet. This workout has come about thanks to the considerable amount of regulatory suitable inquiries Medidata gets from sponsors and businesses managing trials in research. The daily life science field is eager to have the choice to leverage electronic means for consenting demo participants but are unsure of the regulatory positions on the subject matter. The only way to search for clarity on this subject matter was to immediately have interaction with suitable authorities.

The research to begin with centered on the nations around the world in the European geographic region but has advanced to other regions which include Asia Pacific and the Americas. The research prioritized nations around the world where there was an aspiration to utilize electronic educated consent by businesses managing scientific trials.

This white paper is the first in a series to supply an overview of findings from the Medidata eConsent research as it progresses and as we get additional opinions from suitable bodies. This paper highlights the vital themes that different bodies have so far communicated.